Stock Screener App

Frei -

Installieren

24.74

4.52% 1.07

Nurix Therapeutics Inc (NRIX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Nurix Therapeutics Inc-Aktie (NRIX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-05-31	2026-02-28	2025-11-30	2025-08-31	2025-05-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	44.64% 9.043	6.252	13.58	7.894	44.06
Operating Expenses	4.56% 103.25	98.75	96.67	99.28	92.38
Depreciation and Amortization	2.69% 2.255	2.196	2.12	2.028	2.242
Operating Income/Loss	1.85% -94.20	-92.50	-83.09	-91.39	-48.32
Income/Loss From Continuing Operations Before Tax	-89.81	-	-78.22	-86.42	-42.70
Income Tax Expense/Benefit	-0.271	-	-	-	0.76
Net Income/Loss	2.71% -89.53	-87.17	-78.22	-86.42	-43.46
Basic Average Shares	0.92% 111.08	110.07	2.7974	84.16	83.88
Diluted Average Shares	0.92% 111.08	110.07	2.7974	84.16	83.88
Basic Earnings Per Share	2.53% -0.81	-0.79	-0.83	-1.03	-0.52
Diluted Earnings Per Share	2.53% -0.81	-0.79	-0.83	-1.03	-0.52
Common Stock Dividends	-	-	-	-	-

ZLAB

$23.60

4.89%

PGEN

$7.355

0.00%

DYN

$15.23

1.30%

BEAM

$24.40

3.17%

NAMS

$20.96

4.75%

RCUS

$22.90

1.64%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters